Disseminated sporotrichosis in a person with human immunodeficiency virus disease.

Vhudzani Tshisevhe, Lebogang Skosana, Kagiso Motse, Tinashe Maphosa, Barend Mitton
Author Information
  1. Vhudzani Tshisevhe: Lancet Laboratories, Rustenburg, South Africa. ORCID
  2. Lebogang Skosana: Faculty of Health Sciences, Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa. ORCID
  3. Kagiso Motse: Department Internal Medicine, Job Shimankana Tabane Hospital, Rustenburg, South Africa. ORCID
  4. Tinashe Maphosa: Faculty of Health Sciences, Department Dermatology, University of Pretoria, Pretoria, South Africa. ORCID
  5. Barend Mitton: Faculty of Health Sciences, Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa. ORCID

Abstract

INTRODUCTION: Disseminated sporotrichosis is an incapacitating infection caused by the dimorphic fungus . Because this condition may mimic the presentation of tuberculosis, syphilis and other bacterial infections, the diagnosis may be missed or delayed.
CASE PRESENTATION: We describe a case of disseminated sporotrichosis in a patient with poorly controlled human immunodeficiency virus infection. The patient was initially treated for bacterial skin infections. The differential diagnosis also included tuberculosis and syphilis. Only after appropriate specimens had been sent for microbiological and histopathological investigations was the diagnosis of disseminated sporotrichosis made and appropriate treatment started. The patient showed a good clinical response to itraconazole.
CONCLUSION: This report highlights the importance of having a high index of suspicion of endemic mycoses when managing immunocompromised patients. The report also demonstrates that a delay in the diagnosis of sporotrichosis increases morbidity and results in unnecessary and inappropriate treatment with associated costs and adverse effects.

Keywords

References

Clin Infect Dis. 2000 Apr;30(4):684-7 [PMID: 10770730]
An Bras Dermatol. 2017 Sep-Oct;92(5):606-620 [PMID: 29166494]
J Fungi (Basel). 2018 Jul 20;4(3): [PMID: 30036959]
Med Mycol. 2015 Jan;53(1):3-14 [PMID: 25526781]
PLoS Negl Trop Dis. 2015 Sep 25;9(9):e0004096 [PMID: 26407300]
Infection. 2015 Jun;43(3):267-76 [PMID: 25701221]
J Fungi (Basel). 2017 Feb 10;3(1): [PMID: 29371525]
Am J Ophthalmol Case Rep. 2020 Aug 20;20:100898 [PMID: 32875165]
Lancet Infect Dis. 2019 Nov;19(11):e385-e391 [PMID: 31473127]
J Clin Pharm Ther. 2001 Jun;26(3):159-69 [PMID: 11422598]
Int J Infect Dis. 2011 Oct;15(10):e727-9 [PMID: 21719337]
J Fungi (Basel). 2019 Jan 11;5(1): [PMID: 30641918]
J Fungi (Basel). 2018 May 23;4(2): [PMID: 29882883]
Adv Skin Wound Care. 2020 Sep;33(9):1-3 [PMID: 32813486]
Clin Infect Dis. 1995 Oct;21(4):981-5 [PMID: 8645851]
Dermatol Online J. 2017 Jul 15;23(7): [PMID: 29469701]
J Fungi (Basel). 2018 Jul 31;4(3): [PMID: 30065160]
Med Mycol. 2018 Apr 1;56(suppl_1):126-143 [PMID: 29538731]
Clin Microbiol Rev. 2011 Oct;24(4):633-54 [PMID: 21976602]
Case Rep Dermatol. 2018 Oct 24;10(3):231-237 [PMID: 30519169]
Infect Dis Clin North Am. 2006 Sep;20(3):645-62, vii [PMID: 16984873]
Clin Infect Dis. 2007 Nov 15;45(10):1255-65 [PMID: 17968818]

Word Cloud

Similar Articles

Cited By